The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tiogiva, 18 microgram, inhalation powder, hard capsule

Glenmark Pharmaceuticals Nordic ABPA22815/002/001

Main Information

Trade NameTiogiva, 18 microgram, inhalation powder, hard capsule
Active SubstancesTiotropium
Dosage FormInhalation powder, hard capsule
Licence HolderGlenmark Pharmaceuticals Nordic AB
Licence NumberPA22815/002/001

Group Information

ATC CodeR03BB04 tiotropium bromide


License statusAuthorised
Licence Issued12/02/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back